Coursera COUR
$3.43 −$0.02 (-0.58%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $3.40 -0.87%
Open$3.44
Prev close$3.45
Day range$3.39 – $3.57
Volume5.86M
Market cap$868.82M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$376.70M+94.0% YoY
Operating profit$1.90M+112.2% YoY
Net profit-$25.60M-197.7% YoY
Diluted EPS-$0.10-100.0% YoY
Free cash flow$7.40M-74.2% YoY
Operating cash flow$15.50M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin57.0%
Operating margin-4.7%
Net margin-14.4%
Return on equity-18.1%
Return on assets-10.9%
Return on invested capital-20.2%
Current ratio1.37
Liabilities / assets41.4%
Cash & investments$775.50M
Net cash (debt)$775.50M
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $376.70M | $298.60M | $195.70M | $757.50M | $196.90M |
| Total Operating Revenue | $376.70M | $298.60M | $195.70M | $757.50M | $196.90M |
| Cost of Revenue | $156.60M | $125.20M | $87.10M | $344.10M | $90.10M |
| Gross Profit | $220.10M | $173.40M | $108.60M | $413.40M | $106.80M |
| Operating Expense | $218.20M | $178.30M | $133.90M | $491.70M | $139.10M |
| Selling and Admin Expenses | $166.10M | $134.60M | $102.60M | $370.10M | $106.30M |
| -Selling & Marketing Expense | $129.50M | $104.00M | $69.30M | $255.70M | $67.90M |
| -General & Admin Expense | $36.60M | $30.60M | $33.30M | $114.40M | $38.40M |
| Research & Development | $52.10M | $43.70M | $31.30M | $121.60M | $32.80M |
| Operating Profit | $1.90M | -$4.90M | -$25.30M | -$78.30M | -$32.30M |
| Net Non-Operating Interest Income (Expense) | $6.80M | $7.70M | $7.10M | $32.00M | $7.90M |
| Non-Operating Interest Income | $6.80M | $7.70M | $7.10M | $32.00M | $7.90M |
| Other Income (Expense) | -$31.70M | -$81.10M | -$900,000.00 | $400,000.00 | -$400,000.00 |
| Special Income (Charges) | -$30.80M | -$79.80M | $0.00 | $900,000.00 | $0.00 |
| -Less:Restructuring and Mergern & Acquisition | $30.80M | $79.80M | $0.00 | -$900,000.00 | $0.00 |
| Other Non-Operating Income (Expenses) | -$900,000.00 | -$1.30M | -$900,000.00 | -$500,000.00 | -$400,000.00 |
| Pretax Profit | -$23.00M | -$78.30M | -$19.10M | -$45.90M | -$24.80M |
| Tax | $2.60M | $2.10M | $1.40M | $5.10M | $2.00M |
| Net Profit | -$25.60M | -$80.40M | -$20.50M | -$51.00M | -$26.80M |
| Profit from Continuing Operations | -$25.60M | -$80.40M | -$20.50M | -$51.00M | -$26.80M |
| Net Income to Parent Company | -$25.60M | -$80.40M | -$20.50M | -$51.00M | -$26.80M |
| Net Income to Common Stockholders | -$25.60M | -$80.40M | -$20.50M | -$51.00M | -$26.80M |
| Basic EPS | -$0.10 | -$0.34 | -$0.12 | -$0.31 | -$0.16 |
| Diluted EPS | -$0.10 | -$0.34 | -$0.12 | -$0.31 | -$0.16 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.81B | $1.95B | $1.00B | $1.00B | $1.00B |
| Total Current Assets | $1.00B | $1.22B | $893.40M | $898.10M | $898.10M |
| Cash and Cash Equivalents & Short-Term Investments | $775.50M | $982.20M | $789.80M | $792.60M | $792.60M |
| -Cash and Cash Equivalents | $670.60M | $871.70M | $789.80M | $792.60M | $792.60M |
| -Short Term Investments | $104.90M | $110.50M | – | – | – |
| Receivables | $140.00M | $158.80M | $60.00M | $65.40M | $65.40M |
| -Accounts Receivable | $126.50M | $146.80M | $45.70M | $58.00M | $58.00M |
| -Other Receivables | $13.50M | $12.00M | $14.30M | $7.40M | $7.40M |
| Current Deferred Assets | $32.20M | $25.90M | $19.00M | $19.60M | $19.60M |
| Other Current Assets | $52.90M | $54.50M | $24.60M | $20.50M | $20.50M |
| Total Non-Current Assets | $804.80M | $726.40M | $107.10M | $101.90M | $101.90M |
| Net PPE | $57.10M | $55.00M | $45.50M | $43.40M | $43.40M |
| -Gross PPE | $183.40M | $174.60M | $126.00M | $118.30M | $118.30M |
| -Accumulated Depreciation | -$126.30M | -$119.60M | -$80.50M | -$74.90M | -$74.90M |
| Investments and Advances | $110.00M | – | – | – | – |
| Goodwill and Other Intangible Assets | $593.00M | $619.00M | $30.90M | $27.10M | $27.10M |
| -Goodwill | $182.70M | $182.70M | – | – | – |
| -Other Intangible Assets | $410.30M | $436.30M | $30.90M | $27.10M | $27.10M |
| Other Non-Current Assets | $44.70M | $52.40M | $30.70M | $31.40M | $31.40M |
| Total Liabilities | $748.10M | $780.80M | $368.70M | $364.30M | $364.30M |
| Total Current Liabilities | $728.40M | $768.10M | $362.40M | $357.90M | $357.90M |
| Payables | $63.10M | $53.80M | $31.00M | $29.80M | $29.80M |
| -Other Payable | $63.10M | $53.80M | $31.00M | $29.80M | $29.80M |
| Current Deferred Liabilities | $458.50M | $498.40M | $200.10M | $180.90M | $180.90M |
| Other Current Liabilities | $149.90M | $159.30M | $109.90M | $110.50M | $110.50M |
| Total Non-Current Liabilities | $19.70M | $12.70M | $6.30M | $6.40M | $6.40M |
| Non-Current Deferred Liabilities | $3.20M | $3.00M | $1.50M | $1.40M | $1.40M |
| Other Non-Current Liabilities | $16.50M | $9.70M | $4.80M | $5.00M | $5.00M |
| Total Equity | $1.06B | $1.17B | $631.80M | $635.70M | $635.70M |
| Stockholders' Equity | $1.06B | $1.17B | $631.80M | $635.70M | $635.70M |
| Capital Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $2.10B | $2.18B | $1.56B | $1.55B | $1.55B |
| Retained Earnings | -$1.04B | -$1.01B | -$931.70M | -$911.20M | -$911.20M |
| Gains/Losses Not Affecting Retained Earnings | $0.00 | $100,000.00 | – | – | – |
| Less: Treasury Stock | – | $0.00 | $0.00 | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $15.50M | -$19.80M | $14.60M | $108.70M | $5.80M |
| Net cash flow from continuing operations | $15.50M | -$19.80M | $14.60M | $108.70M | $5.80M |
| Net Income from Continuing Operations | -$25.60M | -$80.40M | -$20.50M | -$51.00M | -$26.80M |
| Depreciation & Depletion & Amortization | $34.60M | $22.50M | $7.50M | $28.80M | $7.00M |
| Other Non-Cash Items | $300,000.00 | $700,000.00 | $500,000.00 | -$300,000.00 | $0.00 |
| Change in Working Capital | -$19.90M | -$2.20M | $6.80M | $32.40M | $900,000.00 |
| -Change in Receivables | $18.10M | -$1.50M | $5.40M | -$5.70M | -$6.70M |
| -Change in Prepaid Assets | -$7.40M | -$5.60M | -$3.00M | $7.40M | $1.20M |
| -Change in Payables and Accrued Expense | $9.10M | $19.60M | -$14.90M | $9.70M | $3.20M |
| -Change In Other Working Capital | -$39.70M | -$14.70M | $19.30M | $21.00M | $3.20M |
| Net cash flow from investing | -$105.60M | $200.10M | -$11.60M | -$30.20M | -$7.80M |
| Net Cash Flow from Continuing Investing Activities | -$105.60M | $200.10M | -$11.60M | -$30.20M | -$7.80M |
| Capital Expenditure | -$7.80M | -$7.40M | -$5.60M | -$18.10M | -$4.80M |
| Net PPE Purchase and Sale | -$300,000.00 | -$300,000.00 | -$200,000.00 | -$1.50M | -$400,000.00 |
| Net Business Purchase and Sale | $0.00 | – | – | $0.00 | $0.00 |
| Net Investment Purchase and Sale | -$94.70M | – | – | $0.00 | $0.00 |
| Net Other Investing Changes | -$2.80M | -$5.10M | -$5.80M | -$10.60M | -$2.60M |
| Financing Cash Flow | -$110.70M | -$96.70M | -$5.70M | -$13.50M | -$3.10M |
| Net Cash Flow from Continuing Financing Activities | -$110.70M | -$96.70M | -$5.70M | -$13.50M | -$3.10M |
| Net Common Stock Issuance | -$103.40M | – | – | $0.00 | $0.00 |
| Proceeds from Stock Option Exercised | $200,000.00 | $3.00M | $200,000.00 | $14.10M | $2.70M |
| Net Other Financing Charges | -$7.50M | -$12.40M | -$5.90M | -$27.60M | -$5.80M |
| Ending Cash Balance | $673.10M | $874.00M | $790.70M | $793.40M | $793.40M |
| Net Change in Cash | -$200.80M | $83.60M | -$2.70M | $65.00M | -$5.10M |
| Beginning Cash Balance | $874.00M | $790.70M | $793.40M | $728.40M | $798.50M |
| Effect of Exchange Rate Changes | -$100,000.00 | – | – | – | – |
| Free Cash Flow | $7.40M | -$27.50M | $8.80M | $89.10M | $600,000.00 |
No comments yet — be the first to weigh in on COUR.
Sign in to join the discussion.